Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s ...

Japan's Toyota Motor is expected to post its second consecutive quarterly profit drop when it reports third-quarter earnings ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...

Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...

The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Amazon almost doubled its profits in 2024 compared to the year before, but it missed some analysts expectations in its cloud ...

Yum! Brands, Inc. (NYSE:YUM) shares are trading higher on Thursday. The company reported fourth-quarter adjusted earnings per ...

Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER growth in Q4 and over 660 new system placements in 2024. QuantiFERON grew ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

We recently compiled a list of the 7 High Growth Travel Services Stocks For 2025. In this article, we are going to take a ...